| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.87▲ | 5.84▲ | 5.79▲ | 5.46▲ | 5.15▲ |
| MA10 | 5.85▲ | 5.75▲ | 5.66▲ | 5.25▲ | 4.83▲ |
| MA20 | 5.85▲ | 5.62▲ | 5.50▲ | 5.05▲ | 4.60▲ |
| MA50 | 5.75▲ | 5.41▲ | 5.27▲ | 4.74▲ | 6.82▼ |
| MA100 | 5.63▲ | 5.25▲ | 5.11▲ | 4.50▲ | N/A |
| MA200 | 5.46▲ | 5.10▲ | 4.92▲ | 4.50▲ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.021▲ | 0.039▲ | 0.069▲ | 0.519▲ |
| RSI | 64.708▲ | 75.634▲ | 75.869▲ | 70.261▲ | 52.903▲ |
| STOCH | 68.958 | 93.798▲ | 86.796▲ | 84.033▲ | 80.057▲ |
| WILL %R | -40.741 | -10.891▲ | -9.016▲ | -4.762▲ | -3.200▲ |
| CCI | 159.694▲ | 122.524▲ | 122.324▲ | 214.808▲ | 224.901▲ |
| ▲ RSI&STOCH | $BIOA Overbought RSI + Stochastic | Set Alert |
| ▲ RSI | $BIOA RSI(14) Crossed Above 70 | Set Alert |
| ▲ BREAK | $BIOA Price Breaks 60 Days High | Set Alert |
| ▲ BREAK | $BIOA Price Breaks 30 Days High | Set Alert |
| ▲ BREAK | $BIOA Price Breaks 20 Days High | Set Alert |
| ▲ BREAK | $BIOA Price Breaks 10 Days High | Set Alert |
|
Sunday, September 28, 2025 11:49 PM
BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that lecanemab (Leqembi) has been approved for once every four weeks intravenous (IV) maintenance dosing for the ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/25 | 5.50 | 5.94 | 5.50 | 5.88 | 210,200 |
| 29/09/25 | 5.49 | 5.49 | 5.325 | 5.45 | 74,000 |
| 26/09/25 | 5.22 | 5.45 | 5.15 | 5.42 | 144,600 |
| 25/09/25 | 5.27 | 5.27 | 5.10 | 5.22 | 117,300 |
| 24/09/25 | 4.94 | 5.34 | 4.94 | 5.31 | 254,800 |
| 23/09/25 | 5.11 | 5.21 | 4.90 | 4.94 | 89,400 |
| 22/09/25 | 4.95 | 5.15 | 4.878 | 5.11 | 113,500 |
| 19/09/25 | 5.22 | 5.29 | 4.88 | 4.90 | 700,300 |
| 18/09/25 | 5.08 | 5.28 | 5.03 | 5.22 | 206,100 |
| 17/09/25 | 4.85 | 5.11 | 4.84 | 5.00 | 194,300 |
|
|
||||
|
|
||||
|
|